Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @ncats_nih_gov
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ncats_nih_gov
-
Prikvačeni tweet
Don’t miss this opportunity to network with patients, patient advocates, health care providers, researchers and others at
#RDDNIH on Friday, February 28, 2020. Together, we can share ideas and address the challenges that#RareDiseases pose. Register today! http://bit.ly/35jGDHY pic.twitter.com/1T8Qv4wyzY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Repurposing existing drugs for new uses has great potential for treating the many diseases still without a cure. Christine Colvis, Ph.D., director of the drug development partnerships programs, shares how NCATS is shaking up the research pipeline: https://www.pharmavoice.com/article/2020-02-pipeline-pathways/ …pic.twitter.com/HcdOeq0Inw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Network with patients, patient advocates, health care providers, researchers, industry partners and others at this year’s
#RDDNIH. Together, we can share information and work to address the challenges that#RareDiseases pose. Register today! https://go.usa.gov/xdrgY pic.twitter.com/a4UlEmvGmY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
“Microgravity gives us new ways to investigate old problems here on earth.”
@drlucieinthesky shares how#ChipsInSpace is exploring new frontiers! Learn more: http://www.bio-itworld.com/2020/02/03/will-research-in-space-make-science-fiction-come-true.aspx …#NIHSpaceProjectshttps://twitter.com/bioitworld/status/1224301842819100673 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
NCATS proslijedio/la je Tweet
Great to see our
@ncats_nih_gov own@drlucieinthesky doing her thing at@NASA. For a brief primer on why#TissueChipsinSpace is an important program, see: https://ncats.nih.gov/tissuechip/projects/space …https://twitter.com/drlucieinthesky/status/1223788736074469376 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
There's still time to register for
#RareDiseaseDay at NIH?
Join NCATS and @NIHClinicalCntr to hear about the latest collaborative research for#RareDiseases: https://go.usa.gov/xdrgY#RDDNIHpic.twitter.com/Z1aSXmXZRu
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
If you are attending the
@KeystoneSymp for Pain, don’t miss the director of NCATS’ Stem Cell Translation Laboratory, Dr. Singec! He will be at the Workshop on New Resources for Therapeutic Discovery in the Grays Peak room at 2:30 p.m. MST on 2/3/20.https://twitter.com/NIH_CommonFund/status/1222849705748549632 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#MeetTheScientist: Tao Deng, Ph.D., is a research scientist currently working on disease modeling and therapeutic strategies for fighting the#OpioidCrisis and addressing pain-related diseases. Learn more about his background: https://go.usa.gov/xdxrf pic.twitter.com/pl6txIGCXW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
NCATS proslijedio/la je Tweet
Thank you to all the partners, panelists and speakers who contributed to the Workshop on Expanding AAV Manufacturing Capacity for Rare Disease Gene Therapies!
#NCATSGeneTherapy#AAV#GeneTherapyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Join us for
#RareDiseaseDay at@NIH on February 28! This year’s event will feature discussions on personalized medicine, shortening the diagnostic odyssey, improving access to#RareDiseases and more! Learn more about the event: https://go.usa.gov/xpVbT#RDDNIHpic.twitter.com/eifRtEOZRE
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Reminder: Join us for a webinar with
@uspto TODAY at 1pm ET to get essential IP advice for#smallbiz commercialization. Register:https://bit.ly/2YhPPe2Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Day 2 of The Workshop on Expanding AAV Manufacturing Capacity for RD Gene Therapies is happening now. Tune into the Videocast is now: https://videocast.nih.gov/live.asp?live=35799 …
#NCATSGeneTherapyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
NCATS proslijedio/la je Tweet
We're hosting a virtual workshop on
#DataMetrics for#DataRepositories and#knowledgebases on 02/19. Learn more and register: https://go.usa.gov/xdgrm#NIH#OpenData#FAIRData#research#datapic.twitter.com/FSBzJF6jF5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
On Monday, NCATS’ Sam Michael accompanied Aviv Elor, a Ph.D. student from
@ucsc & previous@NIH undergrad researcher with NCATS, who presented on exploring how mixed reality systems could be used to help researchers interact with microscopic data at#SLAS2020. Congrats, Aviv!pic.twitter.com/UtpGEI5LWN
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Workshop on Expanding AAV Manufacturing Capacity for RD Gene Therapies (Day 1) - the Videocast is now available: http://ow.ly/wIFo50y7bTI
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#DYK more than 7,000#RareDiseases have been identified, but approved drugs are available for only 500? Find out how the NCATS Pharmaceutical Collection can help scientists discover potential new uses for existing drugs: https://go.usa.gov/xdxrM pic.twitter.com/uc8utGQjXu
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Do you need help getting your research ideas patented? Join us for a webinar on
#IP protection with@ncats_nih_gov &@uspto Wed., Jan. 29, at 1 pm ET and learn how#NCATSsbir#STTR programs can advance your innovation. Register: https://bit.ly/2YhPPe2 pic.twitter.com/utCuAyjTfP
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The Expanding AAV Manufacturing Capacity for
#RareDisease Gene Therapies Workshop begins today! Attendees will explore—
Logistical bottlenecks
Master file best practices & opportunities
Analytics & lot release testing
Stay tuned to the videocast! http://bit.ly/38FixJR pic.twitter.com/xK76NeYm9u
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kick off the new year with our first newsletter of 2020!
Get the latest in #RDDNIH news, find out how#CTSAprogram researchers are working to advance telehealth, and more! http://bit.ly/2R2C9lb pic.twitter.com/jeaJl9EtMPHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
As
#RareDiseaseDay at NIH approaches, NCATS Director Chris Austin, M.D., shares his encounter w/an end-stage ALS patient, over 30 yrs ago—“I have come to realize that#RareDiseases, while intensely personal, are also an urgent#PublicHealth issue.” https://go.usa.gov/xVZtV#RDDNIHpic.twitter.com/ea0T93Xtm9
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Attending this year’s
@Expanded_Access Summit in Washington, D.C.? Don’t miss NCATS Director Dr. Christopher Austin’s keynote address on clinical discovery through treatment of wider ranges of patients at 1:15 p.m. ET tomorrow! View the agenda: https://easummit.net/agenda pic.twitter.com/nlGbvF82bn
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
) and honestly it’s always the